Notably, in specific malignancies such as hepatocellular carcinoma, lung cancer, and melanoma, BTLA expression is upregulated on TILs, indicating an immune escape mechanism employed by cancer cells. The gene discussed is BTLA; the disease is hepatocellular carcinoma.